Dear members of the SB, As part of the strategy to resolve the worldwide shortage of thrombolytic therapy, the BSC has been informed that Boehringer-Ingelheim will temporarily produce Actilyse vials...
Europe is failing to provide adequate stroke care and support The scale of stroke care crisis is laid bare by new data release New data collected as part of the Stroke Action Plan for Europe (SAP-E)...
On April 14, the ESO published their 4th information letter about alteplase and tenecteplase shortage in Europe.
Thrombolytic drug shortage is expected to last until 2024. The manufacturing company is limiting supply to all countries worldwide. Currently, the impact on future drug delivery is still unclear....
Voor de 2022 editie van Wereld Beroertedag organiseren verschillende ziekenhuizen regionale wandelingen, met de steun van de Belgian Stroke Council. Dit initiatief heet “FAST 4-ward”. Via de app...
We support the Stroke Alliance for Europe (SAFE) on European Stroke Awareness Day (Tuesday 10 May) to raise awareness of #StrokePrevention. High blood pressure is one of 10 key modifiable risk...
For the European Stroke Awareness Day (May the 11th), The European Stroke Organisation and the Stroke Alliance for Europe are asking Europe officials to sign the Declaration of the Stroke Action...
Pascal Lecomte, president of the Stroke&Go patient organisation and member of the Belgian Stroke Council produced a video in order to disseminate information about stroke. Let's be aware! Let...
The Belgian Society on Thrombosis and Haemostasis recently published a practice guideline on the rare occurrence of Thrombocytopenia with Thrombosis after COVID-19 Vaccination. We encourage all...